Infographic Brochure Index and sample pages

Industry Report

Generic and innovative drugs market in Hungary

Market analysis and development forecasts for 2018-2023

This product is also available in Polish

Generic and innovative drugs market in Hungary

Market analysis and development forecasts for 2018-2023

Infographic Brochure Index and sample pages
Other versions: Polish
Sector: Pharmacy and healthcare
Country: Hungary

This concise yet comprehensive market report supplies profiles of the leading manufacturers of generic and innovative drugs on the Hungarian market.

Topics covered include best-selling pharmaceuticals in both categories, recent and planned regulatory changes, trends, and changes to the country's reimbursement list and procedures. Also discussed are development forecasts for 2018-2023 for the markets of generic and innovative drugs as well as total pharmaceutical market.

Content Benefits Users Table of Contents ?
Content

What is the content of the report?

  • Historical value of the generic and innovative drugs market in Hungary as well as the total pharmaceutical market value
  • Share of Hungary's pharmaceutical market captured by generic and innovative drugs
  • Generic drugs market value, growth, and prospects for growth in 2018-2023
  • Innovative drugs market dynamics, value, and development in 2018-2023
  • Total pharmaceutical market dynamics, value, and development in 2018-2023
  • Size, earnings and operations of Hungary’s largest active manufacturers of generic and innovative drugs
  • Recent and expected changes and trends on the generic and innovative drugs market in Hungary and their influence on market dynamics
  • Current reimbursement procedures and lists in Hungary and upcoming changes
  • Pricing regulations and permitted markups for drugs in Hungary
  • Regulations on patent expiration periods, SPCs, and data exclusivity periods in Hungary.
Benefits

Why to buy the report?

PMR recommends using this analysis for:

  • Decision making with regard to pharmaceutical market entry in Hungary
  • Estimating the growth potential of Hungary’s market for generic and innovative drugs for budgeting processes and building corporate strategy
  • Analysing the competition and market players
  • Updating corporate product portfolios of medicines offered in Hungary
  • Reviewing pricing and reimbursement guidelines for generic and innovative drugs in Hungary
  • Preparing for upcoming changes to reimbursement policies for generic and innovative drugs in Hungary.
Users

Who benefits from the analysis?

Specialists and managers from sales, marketing, strategy and development departments from:

  • Companies that manufacture and distribute generic and innovative drugs on the Hungarian market
  • Businesses planning to enter the pharmaceutical market in Hungary
  • Agencies offering advertising and marketing support for the pharmaceutical sector
  • Logistic companies operating in Hungary
  • Chambers of commerce, trade organisations, universities, government agencies
  • Investment firms, banks and brokerage houses
  • Other businesses involved in the Hungarian pharmaceutical sector and their market analysts, business consultants, and research professionals.
Table of Contents
  • Methodology
  • Executive summary

More info

For details on price and content please call:
+48 782 011 000
or email sales@pmrcorporate.com

Other versions: Polish
Sector: Pharmacy and healthcare
Country: Hungary

Unlimited sharing and use of the Product inside one Organisation.

For more information please visit: mypmr.pro/terms-and-conditions

This content is available for current PMR clients. If you are a client please log-in or contact us for more information at: +48 782 011 000.

Jest to zawartość dostępna dla obecnych klientów PMR. Jeśli jesteś klientem, zaloguj się lub skontaktuj się z nami, aby uzyskać więcej informacji: +48 782 011 000.